Physical AI News (Japan)

Physical AI, robotics and compute — reported from Japan.

日本語
· Industry· 日本語で読む

leaderobot.com Reports Release of ‘Top 20 Innovative Companies in Brain-Computer Interfaces’ Ranking

leaderobot.com reported the release of a ranking of companies in the brain-computer interface field. The information provided is a secondary report and includes no primary source that would allow the selection criteria to be independently verified. Previous coverage by this newspaper has reported different types of progress in fundraising, clinical trials, policy and the formation of industry hubs.

What happened

On November 17, 2026, leaderobot.com reported that the “2026 Top 20 Innovative Companies in Brain-Computer Interfaces” ranking had been released.

Analysis

What can be confirmed from this report is that leaderobot.com reported the release of a company ranking. The ranking presents a list of companies, but the information provided is not enough to independently verify the selection criteria, the date of evaluation or the sources used to confirm each company’s position. The release should therefore not be treated as evidence of companies’ clinical progress or commercialization achievements; it needs to be checked against individual public information. Previous coverage by this newspaper has documented different types of progress. Brain Tiger Technology completes fundraising of about 700 million yuan reported on fundraising and a fully implantable system at the registered clinical trial stage. Meanwhile, Clinical cases in brain-computer interfaces and industrial promotion efforts in Wuhan covered a meeting by government officials. In addition, [Brain-computer interface cluster in Chengdu grows, as Western China Brain Valley’s specialized buildings draw closer to West China-affiliated hospitals](/news/seito-no-noukinou-kanren-kyoten-kakujuu-wo-leaderobot-com-ga-0e623e) examined the clustering of companies and research hubs. These concern different areas—funding, clinical trials, policy and hubs—and their progress cannot necessarily be compared using the same yardstick. To understand the industry’s structure, it is important to distinguish not only companies’ technical approaches but also their stages in clinical trials and registration, preparations for commercialization, and ties to regional research and medical hubs. For example, the amount raised indicates one aspect of a company’s resources, but does not by itself establish clinical efficacy or sustained use. Government meetings and the formation of hubs should also be distinguished from concrete clinical or manufacturing outcomes. To use a ranking as a practical basis for comparison, readers need to check which companies were considered, the evaluation criteria and the availability of supporting materials, then compare these with each company’s public information. For details of the cited original source, please consult that source.

Sources

Translated from the Japanese original: /news/leaderobot-com-nou-ki-setsu-kuchi-no-kakushin-kigyou-top20-b-dfbe27. The Japanese version is authoritative if they differ.